Harfterkamp, Myriam <br/><br/>
No evidence for predictors of response to atomoxetine treatment of attention-deficit/hyperactivity disorder symptoms in children and adolescents with autism spectrum disorder.  [electronic resource] 

 -  Journal of child and adolescent psychopharmacology  May 2015 
 - 372-5 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-8992 
<br/><br/><label>Standard No.: </label>10.1089/cap.2014.0142  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adrenergic Uptake Inhibitors--therapeutic use<br/>Atomoxetine Hydrochloride--therapeutic use<br/>Attention Deficit Disorder with Hyperactivity--drug therapy<br/>Autism Spectrum Disorder--complications<br/>Child<br/>Female<br/>Humans<br/>Male